000 01155 a2200337 4500
005 20250513091019.0
264 0 _c19960716
008 199607s 0 0 eng d
022 _a0921-4410
040 _aNLM
_beng
_cNLM
100 1 _aCapranico, G
245 0 0 _aDNA topoisomerase inhibitors.
_h[electronic resource]
260 _bCancer chemotherapy and biological response modifiers
_c1996
300 _a68-87 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aChromosome Aberrations
_xchemically induced
650 0 4 _aChromosome Disorders
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aDNA Topoisomerases, Type I
_xgenetics
650 0 4 _aDrug Interactions
650 0 4 _aEnzyme Inhibitors
_xadverse effects
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xenzymology
650 0 4 _aTopoisomerase I Inhibitors
700 1 _aGiaccone, G
700 1 _aZunino, F
700 1 _aGarattini, S
700 1 _aD'Incalci, M
773 0 _tCancer chemotherapy and biological response modifiers
_gvol. 16
_gp. 68-87
999 _c8638445
_d8638445